pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-382 |
Genomic Coordinates | chr14: 101054306 - 101054381 |
Synonyms | MIRN382, hsa-mir-382, MIR382 |
Description | Homo sapiens miR-382 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-382-5p | ||||||||||||||||||
Sequence | 11| GAAGUUGUUCGUGGUGGAUUCG |32 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | DYRK2 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | dual specificity tyrosine phosphorylation regulated kinase 2 | ||||||||||||||||||||
Transcript | NM_003583 | ||||||||||||||||||||
Other Transcripts | NM_006482 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on DYRK2 | |||||||||||||||||||||
3'UTR of DYRK2 (miRNA target sites are highlighted) |
>DYRK2|NM_003583|3'UTR 1 GCTCACGTCCCCTGATGCTGGTAACCTGAAAGATACGACATTGCTGAGCCTTACTGGGTTGAAAAGGAGTAGCTCAGACC 81 TGTTTTTATTTGCTCAATAACTCTACTCATTTGTATCTTTTCAGCACTTAATTTTAATGTAAGAAAGTTGTTCATTTTGT 161 TTTTATAAAATACATGAGGACAATGCTTTAAGTTTTTATACTTTCAGAAACTTTTTGTGTTCTAAAAGTACAATGAGCCT 241 TACTGTATTTAGTGTGGCAGAATAATAACATCAGTGGCAGGCCACTGATTACTTCATGACTGCCACGCATTTACAGATTG 321 GTGTCAAAGACATTCACTATGTTTTTATGGTTCATGTTATATCCTCCCCAGGGTGACAGCCCCTTAAGGCCCTCCTTTTC 401 CCTCCATGCTCCAGGTCCATGCACAGGTGTAGCATGTCCTGCTTCCGTTTTTCATAAATTAATCTGGGTGTTGGGGGTAG 481 TGGGAGGAGAACGGTCAGAATCAAAGTGACATTCTAAGAAAAACTGTACCTTAGAGATTTTCCTCTAGTGCTCAAACAAA 561 TACAAAATAAGATCCCCAAGGTTTAAACTGCCCAGTTAGCATTCTGACATTCTAAAAGCCGGCAAAGCAGCTTTTAGTGG 641 ATAAATGGGAATGGAAACGTGTGTGTTCCTCCAAATTTTCTAGTATGATCGGTGAGCTGTTTTGTAAAGAAGCCTCATAT 721 TACAGAGTTGCTTTTGCACCTAAATTTAGAATTGTATTCCATGAACTGTTCCTCCCTTTTCTCTGCTTTTCTCCTCTCTG 801 TTCCTCTTTTAATACCACACGTCTGTTGCTTGCATTTAGTTTGTCTTCTTCCTTCAGCTGTGTATCCCAGACTGTTAATA 881 CAGAAAAGAGACATTTCAGCTGTGATTATGACCATTGTTTCATATTCCAATTAAAAAAAGAACAGCAGCCTAGCTACTTA 961 AGGTGGGGATTTCCATAGTTCCAAAGAAGATTTAGCAGATTAGAGTGAGTTCACACTTTTCAGGTGCCACTGTAAGGTTC 1041 TCTCAGCCTGGGAAACTATCAACTCTTTCTTTAAAAAGAAAGAGGGTTGAAAATCCTCTGGACGAACAGAAGTCACTTTG 1121 GCTGTTCAGTAAGGCCAATGTTAACAACACGTTTAGAGGAGGAAAAGTTCAACCTCAAGTTAAATGGTTTGACTTATTCT 1201 TCGTATCATTAGAAGAACCCCAGAGATAGCATTCCTCTATTTTATTTTACTTTCTTTTGGATTGCACTGATTGTTTTTGT 1281 GGGAATGACACTTTATCTGGCAAAGTAACTGAGAGTTTGGTAAAAGAATATTTTCTTCTCTGAATAATAATTATTTTCAC 1361 AGTGAAAATTTCAGTATTTTATCACTAATGTATGAGCAATGATCTATATCAATTTCAAGGCACGTGAAAAAAATTTTTTA 1441 GTATGTGCAATTTAATATAGAAAGATTTCTGCCTGTTTGGACAATAGGTTTTGGGTAGTACAGATTAGGATAAGTAAGCT 1521 TATATATGCACAGAGATTATTGTATTACCTGTAAATTGATTTACAAGTACTTAAAAGCGTGGTCCCCAGTGAGGCCAAGA 1601 AAGTTTCCGGTTAAGTTCTTTAATAATAATCCTACAGTTTATCTTAAGAAAAAAAAAAAGGTTTGAAAAAAACACTTTAA 1681 TTTAGGCTTCGTTGGTTGATGGTGGAAAAAAATGCTCAGGAAATATTTCAGATATTTGCCAAAAAACCAGTAATAAGGTT 1761 ACCTTATTAAAATAGTGATATTTGCTTTACTATTTAAGGTGTCACTGATAAATTAATTTGTACTTCTGTGTTTAGAAATT 1841 ATAGCTTCTTTTCCCTTAGTCAAATTTTTTAGCATATTATACACATTTCTGTGTAATCTGTGGAAGTGCAATAATATGTT 1921 AGTAAGTTACATTTTAAATAATGCTCATGTGACAATACTCCCAATCAATGGCTTATAGAATTTAAAGATCTGTATATTAG 2001 ATTTTGGCTTAAAGGCATGAGAAGTATAAGACTTGGTTTGGTGGCTTTGTAAGACCACCAGCCTCTTAATGATGGTTAGC 2081 TTCTTTAGGTCATTAAATCAATAAAAACATATAATGCTGTTTTGCTCTTCTAATGCTCCTCTTCCATTTCCAGTTATCTT 2161 CACATTTACATTTAAATATACAAACCTGAGCCTGCCATTATTAATTTCCCTATAAAATGACGATACATGTGAACATTTAT 2241 AAATGGACTAATACTGCTTGTCTTTCCCCCACCGCACAAAACTGGTTCTTAAGATGCCAGCAATGAATTTGAGACTATCT 2321 TTATTTATAAATGGAAACCGGAAACTTTTATACCAAACTATAATAATGTGCAGCACTGTAGGGCTTTTTTTTTTTTCCCT 2401 CCAAATACAGTGAAATTTTTTTATTCACAAGAGCTGCCACATCTCAGCATTTAGTAATAGAGCTGCTTTAATAAAATTCT 2481 AGTTTGATTGTCATGTCAAAAAAAGAAAAATGTTGCATCTTTGTGATTTTAAAACATAAATTAATGAAGGCTCTGATAGG 2561 CTATTAGGAGTTGGCTTGGAAACAGTTTTTGGTCTCACAGGTTACCATTGTTTGGGGATGTCTGAGCTGTTTTCAGATCT 2641 AGGAATAGCACAGTGTTGTCTTGTCTTTGGCAGTCTCATTTGGCTCTGTTTCTTGCACCACCAGCGTGTTCATTACCACT 2721 TAAATATATTGCTACAGCAGTGGAACAACAGAGTGGTGCAAGACACTGTAGATTAACGGTAGAGGAGAAATTGTGCCCTT 2801 AGTGTTAACAATGTGCCTTTTGTTCTGAATGCCATGTTGTAGGGCATGCATTTTTTGGCCTCTTTAACTCTTCGAATTCT 2881 AGTCAGTAAGAATGGAACCCATCTCTGCAAAGATACATCTGTCTTAAATATCTAGTTACAGGCCTTAATAGAAACCATAA 2961 GGCATGACTCATCTTCAGGCACTGAAAAAAGATAACCATCAGGTAGTGTTACACAAGGACTTCCTATATTTAAGGGGTTA 3041 AAGATGGTCTTTGTTGTATCTTAACATCAGACTGATTTTTACATTTTTTTTTTGTTATGCTAACACTAGACAAAAATCAA 3121 CTGTATTTGTAAAAATTTACCTCAAACCATTTAATTTTATAGTGTGATTAATCCCAGGGCATTTGGTATGAACCAAAGTG 3201 CATTCCTTTTATATGTGCCTGGCTCTAGTAAGGATGGCCAGGGATTTTTACAATTTGGGTGCAAGGCACTTAAGCCACTT 3281 TTAAACTTAATGGGTGGTTTGGGGTCGTGTTAAATGACTCCATCAGAATGTTAGAAAACACTTTAGGCATCAGTAGCATT 3361 GGGCCATATTGGAATCCTAAAGTGTGAATTATTTTAAGGAGAGCATTCATTTTTGTAATTTTTTTCATCAAAAATATTTC 3441 TGGTAAGCAGAAGACTTTTTAAAAAAACTGATCTGGTCTCGGTAAAGGTTTTAATATTGCCCAACATAATGCTGTAATAG 3521 CATTAAAAAAAGTATTTGTGAACTCTGTTTCTTAGGGGCTTGTACATCTCTCTGCTATGGACATACATAAAATTAATTGT 3601 AATTATACTCAGCTCAACTGCTACAGTTCTGTCTAGGCAGTGGCTTGGGTTTTTATCGAGCAACAACTTAGACACGTGAC 3681 TGTAATATGCTGCAACTGTGTGTACTGAAAATATGTGAAAATGGTTGAATGTGGACTGTGTATATATGTATGTAAAAATT 3761 TCTGTGAGATGCTGCTGTCGCCACTTAACATTAAATATGTTCTAGTGGATTTTAATCCTAGTGGCCAGTTCTATGATACT 3841 GTATGTATTATACAGCTGATGACAGGAGTAAGACTGTTTAGTGAATATCTGTTAAATTTTATTGTTGTGGCCAGAGATAA 3921 TTTCAGAATAAAATTTTAATGTCCTACCTTA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | HEK293 | |||||||||
Disease | 8445.0 | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM714642. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 8445.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset GSM714642 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000344096.3 | 3UTR | CAACAACUUAGACACGUGACUGUAAUAUGCUGCAACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000344096.3 | 3UTR | CAACAACUUAGACACGUGACUGUAAUAUGCUGCAACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
112 hsa-miR-382-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT053778 | PTEN | phosphatase and tensin homolog | 4 | 1 | ||||||||
MIRT060847 | XPR1 | xenotropic and polytropic retrovirus receptor 1 | 1 | 1 | ||||||||
MIRT064748 | CCND2 | cyclin D2 | 2 | 6 | ||||||||
MIRT066666 | DYRK2 | dual specificity tyrosine phosphorylation regulated kinase 2 | 2 | 4 | ||||||||
MIRT077432 | PNPO | pyridoxamine 5'-phosphate oxidase | 2 | 2 | ||||||||
MIRT082804 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT089341 | PCBP1 | poly(rC) binding protein 1 | 2 | 6 | ||||||||
MIRT176641 | SMC3 | structural maintenance of chromosomes 3 | 2 | 2 | ||||||||
MIRT223217 | ZKSCAN5 | zinc finger with KRAB and SCAN domains 5 | 2 | 2 | ||||||||
MIRT229780 | GNL3L | G protein nucleolar 3 like | 2 | 2 | ||||||||
MIRT244332 | ARL4A | ADP ribosylation factor like GTPase 4A | 1 | 1 | ||||||||
MIRT326971 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | 2 | 4 | ||||||||
MIRT369626 | APCDD1 | APC down-regulated 1 | 2 | 2 | ||||||||
MIRT407707 | MXD1 | MAX dimerization protein 1 | 2 | 1 | ||||||||
MIRT437905 | NFIA | nuclear factor I A | 2 | 1 | ||||||||
MIRT438103 | DRD1 | dopamine receptor D1 | 1 | 1 | ||||||||
MIRT439190 | ZNF652 | zinc finger protein 652 | 1 | 1 | ||||||||
MIRT439248 | ZCCHC14 | zinc finger CCHC-type containing 14 | 1 | 1 | ||||||||
MIRT439276 | XPO1 | exportin 1 | 1 | 1 | ||||||||
MIRT439382 | TSPYL1 | TSPY like 1 | 1 | 1 | ||||||||
MIRT439494 | SYT13 | synaptotagmin 13 | 1 | 1 | ||||||||
MIRT439497 | SYNJ2 | synaptojanin 2 | 1 | 1 | ||||||||
MIRT439516 | STT3A | STT3A, catalytic subunit of the oligosaccharyltransferase complex | 1 | 1 | ||||||||
MIRT439564 | SOGA2 | microtubule crosslinking factor 1 | 1 | 1 | ||||||||
MIRT439677 | SERGEF | secretion regulating guanine nucleotide exchange factor | 1 | 1 | ||||||||
MIRT439709 | SAR1B | secretion associated Ras related GTPase 1B | 1 | 1 | ||||||||
MIRT439802 | RBM39 | RNA binding motif protein 39 | 1 | 1 | ||||||||
MIRT439819 | RAPH1 | Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 | 1 | 1 | ||||||||
MIRT439894 | PRNP | prion protein | 1 | 1 | ||||||||
MIRT439921 | PPM1A | protein phosphatase, Mg2+/Mn2+ dependent 1A | 1 | 1 | ||||||||
MIRT439942 | PNMA2 | paraneoplastic Ma antigen 2 | 1 | 1 | ||||||||
MIRT439999 | PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | 1 | 1 | ||||||||
MIRT440023 | PCNXL2 | pecanex homolog 2 | 1 | 1 | ||||||||
MIRT440041 | PARM1 | prostate androgen-regulated mucin-like protein 1 | 1 | 1 | ||||||||
MIRT440180 | MTRNR2L8 | MT-RNR2-like 8 | 1 | 1 | ||||||||
MIRT440191 | MTRNR2L2 | MT-RNR2-like 2 | 1 | 1 | ||||||||
MIRT440195 | MTRNR2L1 | MT-RNR2-like 1 | 1 | 1 | ||||||||
MIRT440198 | MTPN | myotrophin | 1 | 1 | ||||||||
MIRT440303 | LUZP6 | leucine zipper protein 6 | 1 | 1 | ||||||||
MIRT440365 | KIF5C | kinesin family member 5C | 1 | 1 | ||||||||
MIRT440376 | KIAA2022 | neurite extension and migration factor | 1 | 1 | ||||||||
MIRT440514 | HERC2 | HECT and RLD domain containing E3 ubiquitin protein ligase 2 | 1 | 1 | ||||||||
MIRT440626 | FNIP1 | folliculin interacting protein 1 | 1 | 1 | ||||||||
MIRT440679 | FAM199X | family with sequence similarity 199, X-linked | 1 | 1 | ||||||||
MIRT440762 | DYNC1H1 | dynein cytoplasmic 1 heavy chain 1 | 1 | 1 | ||||||||
MIRT440814 | DICER1 | dicer 1, ribonuclease III | 1 | 1 | ||||||||
MIRT440839 | DDOST | dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit | 1 | 1 | ||||||||
MIRT440851 | DAD1 | defender against cell death 1 | 1 | 1 | ||||||||
MIRT440909 | COPS4 | COP9 signalosome subunit 4 | 1 | 1 | ||||||||
MIRT440931 | CLTC | clathrin heavy chain | 1 | 1 | ||||||||
MIRT441003 | CASP3 | caspase 3 | 1 | 1 | ||||||||
MIRT441121 | BBS4 | Bardet-Biedl syndrome 4 | 1 | 1 | ||||||||
MIRT441181 | ARMCX3 | armadillo repeat containing, X-linked 3 | 1 | 1 | ||||||||
MIRT441259 | ADM | adrenomedullin | 1 | 1 | ||||||||
MIRT441796 | EXOSC2 | exosome component 2 | 2 | 2 | ||||||||
MIRT443001 | SLC3A1 | solute carrier family 3 member 1 | 2 | 2 | ||||||||
MIRT445896 | FAM46A | family with sequence similarity 46 member A | 2 | 2 | ||||||||
MIRT445930 | UFL1 | UFM1 specific ligase 1 | 2 | 2 | ||||||||
MIRT447479 | NYAP2 | neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 | 2 | 2 | ||||||||
MIRT450664 | SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 2 | 2 | ||||||||
MIRT454105 | TMEM209 | transmembrane protein 209 | 2 | 2 | ||||||||
MIRT459477 | HIST1H3G | histone cluster 1 H3 family member g | 2 | 2 | ||||||||
MIRT464867 | UBB | ubiquitin B | 2 | 8 | ||||||||
MIRT466300 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT470024 | PTP4A2 | protein tyrosine phosphatase type IVA, member 2 | 2 | 2 | ||||||||
MIRT472335 | NETO2 | neuropilin and tolloid like 2 | 2 | 4 | ||||||||
MIRT472973 | MSANTD3 | Myb/SANT DNA binding domain containing 3 | 2 | 2 | ||||||||
MIRT478514 | CTTN | cortactin | 2 | 6 | ||||||||
MIRT501170 | SLC10A7 | solute carrier family 10 member 7 | 2 | 6 | ||||||||
MIRT501800 | NHLRC3 | NHL repeat containing 3 | 2 | 6 | ||||||||
MIRT504301 | ZNF318 | zinc finger protein 318 | 2 | 6 | ||||||||
MIRT507913 | CALM1 | calmodulin 1 | 2 | 4 | ||||||||
MIRT511139 | MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | 2 | 2 | ||||||||
MIRT512231 | ATXN3 | ataxin 3 | 2 | 6 | ||||||||
MIRT514375 | UBBP4 | ubiquitin B pseudogene 4 | 2 | 6 | ||||||||
MIRT516686 | ZNF860 | zinc finger protein 860 | 2 | 4 | ||||||||
MIRT523197 | HIST1H3F | histone cluster 1 H3 family member f | 2 | 2 | ||||||||
MIRT529767 | SF3B1 | splicing factor 3b subunit 1 | 2 | 2 | ||||||||
MIRT533901 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | 2 | 2 | ||||||||
MIRT534934 | PTGDR | prostaglandin D2 receptor | 2 | 2 | ||||||||
MIRT535125 | PLSCR4 | phospholipid scramblase 4 | 2 | 2 | ||||||||
MIRT536454 | KLHL3 | kelch like family member 3 | 2 | 2 | ||||||||
MIRT537076 | GPR176 | G protein-coupled receptor 176 | 2 | 2 | ||||||||
MIRT537336 | FRAXA | fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation) | 2 | 2 | ||||||||
MIRT537513 | FAM105A | family with sequence similarity 105 member A | 2 | 2 | ||||||||
MIRT544499 | SLC25A46 | solute carrier family 25 member 46 | 2 | 2 | ||||||||
MIRT546072 | VEZF1 | vascular endothelial zinc finger 1 | 2 | 2 | ||||||||
MIRT546537 | NHS | NHS actin remodeling regulator | 2 | 4 | ||||||||
MIRT552796 | YAF2 | YY1 associated factor 2 | 2 | 2 | ||||||||
MIRT559300 | ATXN1 | ataxin 1 | 2 | 2 | ||||||||
MIRT559851 | GSKIP | GSK3B interacting protein | 2 | 2 | ||||||||
MIRT563341 | RPLP0 | ribosomal protein lateral stalk subunit P0 | 2 | 2 | ||||||||
MIRT563969 | RAB6A | RAB6A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT564767 | ZFP36L1 | ZFP36 ring finger protein like 1 | 2 | 2 | ||||||||
MIRT565057 | VAMP3 | vesicle associated membrane protein 3 | 2 | 2 | ||||||||
MIRT565585 | SLC6A8 | solute carrier family 6 member 8 | 2 | 2 | ||||||||
MIRT574166 | ATG10 | autophagy related 10 | 2 | 2 | ||||||||
MIRT612545 | RPAP2 | RNA polymerase II associated protein 2 | 2 | 4 | ||||||||
MIRT613882 | ADO | 2-aminoethanethiol dioxygenase | 2 | 2 | ||||||||
MIRT617251 | SPIC | Spi-C transcription factor | 2 | 2 | ||||||||
MIRT620608 | SAP30 | Sin3A associated protein 30 | 2 | 2 | ||||||||
MIRT620665 | MRPS18C | mitochondrial ribosomal protein S18C | 2 | 2 | ||||||||
MIRT630854 | KLHDC10 | kelch domain containing 10 | 2 | 2 | ||||||||
MIRT661986 | DSN1 | DSN1 homolog, MIS12 kinetochore complex component | 2 | 4 | ||||||||
MIRT686138 | B4GALT7 | beta-1,4-galactosyltransferase 7 | 2 | 2 | ||||||||
MIRT698032 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 2 | ||||||||
MIRT700741 | PLEKHA8 | pleckstrin homology domain containing A8 | 2 | 2 | ||||||||
MIRT716928 | G3BP2 | G3BP stress granule assembly factor 2 | 2 | 2 | ||||||||
MIRT731079 | YBX1 | Y-box binding protein 1 | 3 | 1 | ||||||||
MIRT733642 | TOP1 | DNA topoisomerase I | 2 | 0 | ||||||||
MIRT734728 | NR3C1 | nuclear receptor subfamily 3 group C member 1 | 3 | 0 | ||||||||
MIRT756465 | NR1H4 | nuclear receptor subfamily 1 group H member 4 | 1 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|